Navigation Links
NIH expands national consortium dedicated to transforming clinical and translational research
Date:5/29/2008

Fourteen academic health centers in 11 states are the latest members of the National Institutes of Healths Clinical and Translational Science Award (CTSA) consortium. Creating a unique network of medical research institutions across the nation, the consortium is working to reduce the time it takes for laboratory discoveries to become treatments for patients and to engage communities in clinical research efforts. It also is fulfilling the critical need to train the next generation of clinical and translational researchers. The consortium is led by the National Center for Research Resources (NCRR), a part of the NIH.

With more than half of NIHs funding allocated for basic research, the CTSA consortium is perfectly poised to help move discoveries in the laboratory to improved patient care. The consortium serves as the bridge in this process that allows researchers to perfect and refine existing treatments through interdisciplinary teams that extend to the clinic and community, said NIH Director Elias A. Zerhouni, M.D. Through the consortium, we are better able to leverage expertise and resources across the CTSA institutions, and ultimately maximize NIHs investment in basic research, which should remain a top priority.

The institutions receiving new CTSA funding include (*view descriptions of the CTSA awardees at www.ncrr.nih.gov/ctsa2008):

Albert Einstein College of Medicine of Yeshiva University (New York City)

Boston University (Boston)

Harvard University (Cambridge, Mass.)

Indiana University School of Medicine (Indianapolis)

Northwestern University (Chicago and Evanston, Ill.)

The Ohio State University (Columbus, Ohio)

The Scripps Research Institute (La Jolla, Calif.)

Stanford University (Palo Alto, Calif.)

Tufts University (Boston)

The University of Alabama at Birmingham (Birmingham, Ala.)

Unive
'/>"/>

Contact: Joyce McDonald
Info@ncrr.nih.gov
301-435-0888
NIH/National Center for Research Resources
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Ossur -- leading orthopedic pioneer - expands network to Asia
2. Monsanto expands sponsorship for Peking-Yale Joint Agrobiotechnology Center
3. DHS Expands Biometrics-at-Sea Program to the Florida Straits
4. Springer expands publishing partnership with the Biomedical Engineering Society
5. Science expands Science Signaling, featuring research related to medical advances, and more
6. bioMETRX Expands Engineering and Manufacturing Capabilities
7. Wolves find happy hunting grounds in Yellowstone National Park
8. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
9. ESMO International Symposium on Immunology
10. Story tips from the US Department of Energys Oak Ridge National Laboratory, September 2007
11. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...pid, mysterious death of phytoplankton in the Nort...cientists at Rutgers University and the Woods Hole...ical may hold unexpected promise in cancer researc...pid, or fatty compound, in a virus that has been a...lankton that plays a major role in the global carb...
(Date:11/8/2009)...TH INTELLECTUAL DISABILITIES: AN OPPORTUNITY FOR H...volving adults with intellectual disabilities foun...knowledge after taking a semi-weekly class for fou...ccepted term for mental retardation, have slightly...preventable chronic diseases compared to the gener...
(Date:11/6/2009)...l Center and the Chinese Academy of Sciences (CAS)... on Taste and Smell Research. Organized by Monell ... the first international meeting on taste and smel...cutive Officer, American Association for the Advan...ce magazine, will open the meeting with a plenary ...
Breaking Biology News(10 mins):Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2 248 million NIH grant for heart cell development and study 59898 1 248 million NIH grant for heart cell development and study 59898 2Growing cartilage from stem cells 10456 1Prolonged Use of Pacifier Linked to Speech Problems 59896 1
... prediction program by computer scientists at Wash...sts to predict the very beginnings of gene transcr...rs thereby defining the first exon of the gene. , ...WINSCAN is called N-SCAN. Michael Brent, Ph.D. pro...y in St. Louis, together with Samuel S. Gross, the...
...sults more accurate than PSA , Researchers at the...r have identified a panel of 22 biomarkers that to...ate cancer than the current prostate specific anti.... 22 issue of the New England Journal of Medicine.... 331 prostate cancer patients prior to surgery, an...
...or its therapeutic effect on burned or irritated s... as a healthful additive to your fruits and veggie...gel from the tropical plant that can be used as an...of fresh produce. The gel, which does not appear t...s a safe, natural and environmentally-friendly alt...
Other Biology News:Modification of program enables prediction of gene transcription 2Modification of program enables prediction of gene transcription 3U-M researchers identify new blood test for prostate cancer 2U-M researchers identify new blood test for prostate cancer 3Aloe vera coating may prolong freshness, safety of fruits and vegetables 2
(Date:11/8/2009)..., MOUNTAIN VIEW, Calif. Nov. 5, 2009 Complet...cing company, today announced publication of a rep...etary DNA sequencing platform, including analysis .... The consumables cost for these three genomes seq...rrays ranged from $8,005 for 87x coverage to $1,72...
(Date:11/6/2009)..., AURORA, Ontario, Nov. 6 /PRNewswire-FirstCall/ ...heets: HXBPF) today announced that John Docherty, ...t at Merriman Curhan Ford,s 6th annual Investor Su...l Hotel in New York City. Mr. Docherty will provi...velopment programs L-DOS47 and Topical Interferon ...
(Date:11/6/2009)..., SPRING VALLEY, Calif., Nov. 6 C...warded a Small Business Innovative Research (SBIR)...h and Material command. Under terms of the agreeme...nts (ASRs) for the diagnosis of Dengue virus. ,...at represents a major threat to military forces de...
(Date:11/5/2009)... TRANSPORTATION -- Gone hybrid . . . , Fuel e...iles are now posted at the www.fueleconomy.gov w...oped and maintains for the U.S. Department of Ener...ine of the top 10 vehicles on the best fuel econom...us (51 MPG city; 48 highway). "This list proves th...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...November 6 deCODE genetics,(Nasdaq: DCGN ) today...the,quarter ended September 30, 2008. A conference...rating highlights and a strategic update will,be w...m EST/1pm GMT,(details below)., Operating loss fo...ed,to $22.2 million for the third quarter 2007. Op...
...t to host call and webcast today at 5:00 p.m. East...ent business highlights -, SAN DIEGO, Calif., Nov... ), a biopharmaceutical company focused on,the tre...-related,disorders, today announced unaudited fina...September 30, 2008., Three Months Ended September...
...call scheduled for November 6, 2008 at 1:30 p.m. (... at http://www.adventrx.com , SAN DIEGO, Nov. 6 ...opharmaceutical company focused on in-licensing,de...andidates primarily for,the treatment of cancer, t...h and nine-month periods ended September 30, 2008....
Other Biology Technology:deCODE genetics Announces Third Quarter 2008 Financial Results 2deCODE genetics Announces Third Quarter 2008 Financial Results 3deCODE genetics Announces Third Quarter 2008 Financial Results 4deCODE genetics Announces Third Quarter 2008 Financial Results 5deCODE genetics Announces Third Quarter 2008 Financial Results 6deCODE genetics Announces Third Quarter 2008 Financial Results 7deCODE genetics Announces Third Quarter 2008 Financial Results 8deCODE genetics Announces Third Quarter 2008 Financial Results 9deCODE genetics Announces Third Quarter 2008 Financial Results 10deCODE genetics Announces Third Quarter 2008 Financial Results 11deCODE genetics Announces Third Quarter 2008 Financial Results 12Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 2Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 3Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 4Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 5Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 6Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 7Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 8Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 9ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 2ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 3ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 4ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 5ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 6ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 7ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 8
MHC Volumes 1 & 2 from Promega
Custom Production Service from AbD Serotec
MitoScreen (JC-1) Kit from BD Biosciences Pharmingen
Single-stranded carrier DNA, 3 x 1 ml from Dualsystems Biotech AG
Biology Products: